This bill creates a new regulatory framework specifically for homeopathic drugs sold in the United States. Right now, homeopathic products are regulated like regular drugs, but this bill says they should follow their own set of rules instead. The main idea is to make it easier for people to access homeopathic products while still ensuring they're safe and honestly labeled.

Here's what changes: Homeopathic products won't need FDA approval before being sold, and they won't have to prove their ingredients work through clinical trials like regular drugs do. Instead, they'll be judged safe if they follow standards from the Homeopathic Pharmacopoeia of the United States or other recognized homeopathic standards. Manufacturers still have to follow good manufacturing practices and can't sell products that are contaminated or mislabeled. For products made from potentially dangerous ingredients in their pure form, manufacturers must test to make sure the final product doesn't contain unsafe amounts.

The bill also sets rules for what companies can claim on labels. If a homeopathic product is sold over-the-counter, it must list its intended uses, but these uses only need to be supported by homeopathic references, traditional usage, or peer-reviewed journals—not necessarily FDA-approved clinical trials. Labels must include a disclaimer saying the FDA hasn't evaluated these claims. The bill creates a new advisory committee with representatives from homeopathic practitioners, manufacturers, consumers, and the FDA to help oversee these products and investigate safety reports.